# Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants

> **NCT02573012** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 314 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Placebo matched to prednisone
- **DRUG:** Prednisone
- **BIOLOGICAL:** Tocilizumab

## Key facts

- **NCT ID:** NCT02573012
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-29
- **Primary completion:** 2018-02-09
- **Final completion:** 2018-02-09
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2019-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02573012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02573012, "Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02573012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*